| Original language | English |
|---|---|
| Pages (from-to) | 1066 |
| Journal | Lancet Infectious Diseases |
| Volume | 21 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2021 |
| Externally published | Yes |
Funding
This work is supported by the German Center for Infection Research (DZIF). CL reports personal fees from Chiesi, Gilead, Janssen, Lucane, Novartis, Oxoid, Berlin Chemie, Thermo Fisher, and Oxford Immunotec outside the submitted work. All other authors declare no competing interests. The Research Center Borstel filed TB22 for patenting (EP20158652.6). Members of the DZIF-TB cohort study group are listed in the appendix (pp 1–3) .
| Funders | Funder number |
|---|---|
| Deutsches Zentrum für Infektionsforschung |
Keywords
- Humans
- RNA/blood
- Transcriptome
- Tuberculosis/blood